Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kyalin Biosciences Inc.

Division of Retrophin Inc.
www.kyalinbio.com

Latest From Kyalin Biosciences Inc.

Start-Up Quarterly Statistics, Q4 2013

Life science start-ups raised $1.18 billion in the final quarter of 2013, more than twice the $559.4 million they garnered in the previous quarter, and the most lucrative quarter reported for the group in the history of this START-UP column.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, January 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced November through December 2013

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Retrophin Inc.
  • Senior Management
  • Srinivas Rao, MD, PhD, Pres.
    Sabrina Martucci Johnson, Secretary & Treasurer
    Jeffrey Anderson, PhD, Scientific Advisor
  • Contact Info
  • Kyalin Biosciences Inc.
    Phone: (858) 779-4253
    San Diego, CA
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register